Goldline Pharmaceutical IPO Timeline
The Goldline Pharmaceutical IPO opened for subscription on Tuesday, 12 May 2026, and closed successfully on Thursday, 14 May 2026.
The basis of allotment was finalized on Friday, 15 May 2026. Refunds to unsuccessful applicants were initiated on Monday, 18 May 2026, and shares were credited to the Demat accounts of successful investors on the same day.
The Goldline Pharmaceutical IPO was listed on the BSE SME Platform on Tuesday, 19 May 2026, completing the IPO process.
Goldline Pharmaceutical IPO Important Dates
- IPO Open Date: 12 May 2026
- IPO Close Date: 14 May 2026
- Basis of Allotment: 15 May 2026
- Refund Initiation: 18 May 2026
- Shares Credited to Demat: 18 May 2026
- Listing Date: 19 May 2026
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Goldline Pharmaceutical IPO Timeline (Tentative)
- IPO Open Date
- Tuesday, 12 May 2026
- IPO Close Date
- Thursday, 14 May 2026
- Basis of Allotment
- Friday, 15 May 2026
- Initiation of Refunds
- Monday, 18 May 2026
- Credit of Shares to Demat
- Monday, 18 May 2026
- Listing Date
- Tuesday, 19 May 2026 — NSE & BSE
Important Dates
Open Date
12 May 2026
Close Date
14 May 2026
Basis Of Allotment
15 May 2026
Listing Date
19 May 2026
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
When will the Goldline Pharmaceutical IPO open for subscription?
The Goldline Pharmaceutical IPO subscription opened on Tue, May 12, 2026 and closed on Thu, May 14, 2026.
What is the Goldline Pharmaceutical IPO Allotment Date?
The Goldline Pharmaceutical IPO allotment date was Fri, May 15, 2026. Investors can check their Goldline Pharmaceutical IPO allotment status on the registrar's website using their PAN, application number, or DP/Client ID once the allotment is finalized.
What is the Goldline Pharmaceutical IPO Listing Date?
The Goldline Pharmaceutical IPO was listed on the BSE on Tue, May 19, 2026.
When will Goldline Pharmaceutical IPO shares be credited to the Demat account?
The shares allotted in the Goldline Pharmaceutical IPO were credited to Demat accounts of successful applicants on Mon, May 18, 2026.
What is the complete Goldline Pharmaceutical IPO timeline?
The Goldline Pharmaceutical IPO timeline began with the IPO opening for subcription on Tue, May 12, 2026 and closing on Thu, May 14, 2026. The basis of allotment was finalized on Fri, May 15, 2026. Refunds were initiated, and shares were credited to successful applicants' Demat accounts on Mon, May 18, 2026. The Goldline Pharmaceutical IPO listed on the BSE on Tue, May 19, 2026.
What is the 'Pre-Apply' facility for the Goldline Pharmaceutical IPO?
The Pre-Apply facility allows investors to submit their Goldline Pharmaceutical IPO application up to 2 days before the IPO subscription opens. Your application is saved in advance and will be submitted when the IPO bidding window begins.
If I pre-apply for Goldline Pharmaceutical IPO, when will my order get placed?
If you pre-apply for the Goldline Pharmaceutical IPO, your order is submitted to the stock exchange once the IPO subscription window opens. After the bidding period begins, you will typically receive a UPI mandate request within 24 hours. Your IPO application is considered complete after you approve the UPI mandate and the required funds are blocked in your bank account.